Mediphase Venture Partners is a venture capital firm focusing on health care/life sciences companies.
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance
PatientKeeper's Peter Henderson On Physician Adoption of CPOE – Still a Missing Piece of Meaningful Use Compliance
Relypsa Announces Presentation of Positive Phase 2 Results for RLY5016 at American Society of Hypertension Meeting
Tetraphase Presents Data Demonstrating Robust Activity and Dosing Flexibility of Intravenous and Oral Next-Generation Antibiotic Candidates Targeting Complicated, Multidrug-Resistant Pathogens
© Mediphase Venture Partners
